Why Systematic Review rather than Narrative Review?

참고문헌 (12)

1. "What is a systematic review? Evidence-based medicine" (2009)[URL]
2. Cipriani A, "Comparison of systematic and narrative reviews:the example of the atypical antipsychotics", Epidemiol Psichiatr Soc, 12, pp.146~153 (2003)
3. Han C, "The potential role of atypical antipsychotics for the treatment of posttraumatic stress disorder", J Psychiatr Res, 56, pp.72~81 (2014)
4. Pae CU, "Clinical issues in use of atypical antipsychotics for depressed patients", CNS Drugs, 27(Suppl 1), pp.S39~S45 (2013)
5. Wang HR, "Atypical antipsychotics in the treatment of posttraumatic stress disorder", Clin Neuropharmacol, 36, pp.216~222 (2013)
6. Fountoulakis KN, "Burning issues in the metaanalysis of pharmaceutical trials for depression", J Psychopharmacol, 28, pp.106~117 (2014)
7. Pivac N, "Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related posttraumatic stress disorder", Psychopharmacology (Berl), 175, pp.451~456 (2004)
8. Biederman J, "How informative are open-label studies for youth with bipolar disorder? A meta-analysis comparing open-label versus randomized, placebo-controlled clinical trials", J Clin Psychiatry, 73, pp.358~365 (2012)
9. 배치운, "A Meta-Analysis Comparing Open-Label versus Placebo- Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and Promises", PSYCHIATRY INVESTIGATION, 11(4), pp.371~379 (2014), 대한신경정신의학회[DOI]
10. Canive J, "Quetiapine monotherapy in chronic posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial (P050)", Thematic Meeting for the Collegium Internationale Neuro-psychopharmacologicum (2009)
11. Hickie IB, "Novel melatonin-based therapies: potential advances in the treatment of major depression", Lancet, 378, pp.621~631 (2011)
12. Pae CU, "Agomelatine: a new option for treatment of depression?", Expert Opin Pharmacother, 15, pp.443~447 (2014)

관련 논문AI추천